MOXALACTAM

SynDRA canonical compound SYN0003125 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bone and joint infections \| gram-negative bacterial infections \| gram-positive bacterial infections \| meningitis \| pneumonia \| skin infections \| urinary tract infections
Disease area	infectious disease

All known targets

latamoxef
latamoxef disodium
lamoxactam
moxam
latamoxef sodium
moxalactam disodium
moxalactam disodium salt
Latamoxef
Moxalactam Disodium
Moxam
Shiomarin
Festamoxin
LMOX
Lamoxactam
Latamoxefum
Disodium Moxalactam
Lilly 127935
Ly127935
Sid 734787
Latamoxef (INN)
Latamoxef [INN:BAN]
Latamoxefum [INN-Latin]
Oxa-cephem
S-6059
(6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
1-Oxacephalosporin
7b-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7a-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid
7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid
VUF6C936Z3
CHEBI:599928
S 6059
LY-127935
1 Oxacephalosporin
Latamoxef, Disodium